. . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . "NCT01607957" . . . . . . . . . . "clinical trial"@en . . . . . "2014-01-24T00:00:00Z"^^ . "klinisch onderzoek"@nl . "Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies"@en . "800"^^ . . . . . . . . . "Randomized, Double-blind, Phase 3 Study of TAS-102 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies"@en . . . . . . "RECOURSE"@en . . . . . "Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies"@en . . . . . "2012-06-17T00:00:00Z"^^ . . . . . . . . . . . . . . . . . "Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies"@en . . . . . . . . "ensayu cl\u00EDnicu"@ast . . . . . . . . . . . . . . . . . "18"^^ . . . . . . . . . .